An international team of scientists has identified a surprising factor that accelerates the degradation of lithium-ion batteries leading to a steady ...
NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...